| Year |
Citation |
Score |
| 2023 |
Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Research. 334: 199157. PMID 37364815 DOI: 10.1016/j.virusres.2023.199157 |
0.307 |
|
| 2019 |
Atkins SL, Motaib S, Wiser LC, Hopcraft SE, Hardy PB, Shackelford J, Foote P, Wade AH, Damania B, Pagano JS, Pearce KH, Whitehurst CB. Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1. Antiviral Research. 173: 104649. PMID 31711927 DOI: 10.1016/J.Antiviral.2019.104649 |
0.466 |
|
| 2019 |
Kobayashi E, Hwang D, Bheda-Malge A, Whitehurst CB, Kabanov AV, Kondo S, Aga M, Yoshizaki T, Pagano JS, Sokolsky M, Shakelford J. Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells. International Journal of Molecular Sciences. 20. PMID 31370144 DOI: 10.3390/Ijms20153733 |
0.334 |
|
| 2018 |
Pagano JS, Whitehurst CB, Andrei G. Antiviral Drugs for EBV. Cancers. 10. PMID 29899236 DOI: 10.3390/Cancers10060197 |
0.464 |
|
| 2017 |
Dyson OF, Pagano JS, Whitehurst CB. Translesion Polymerase, pol η, is Required for Efficient Epstein-Barr Virus Infectivity and is Regulated by the Viral Deubiquitinating Enzyme, BPLF1. Journal of Virology. PMID 28724765 DOI: 10.1128/Jvi.00600-17 |
0.511 |
|
| 2015 |
Whitehurst CB, Li G, Montgomery SA, Montgomery ND, Su L, Pagano JS. Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice. Mbio. 6. PMID 26489865 DOI: 10.1128/Mbio.01574-15 |
0.499 |
|
| 2015 |
Bentz GL, Moss CR, Whitehurst CB, Moody CA, Pagano JS. LMP1-induced Sumoylation Influences the Maintenance of EBV Latency Through KAP1. Journal of Virology. PMID 25948750 DOI: 10.1128/Jvi.00711-15 |
0.512 |
|
| 2014 |
Kumar R, Whitehurst CB, Pagano JS. The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity. Journal of Virology. 88: 6411-22. PMID 24672041 DOI: 10.1128/Jvi.00536-14 |
0.537 |
|
| 2013 |
Whitehurst CB, Sanders MK, Law M, Wang FZ, Xiong J, Dittmer DP, Pagano JS. Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase. Journal of Virology. 87: 5311-5. PMID 23449792 DOI: 10.1128/Jvi.03505-12 |
0.538 |
|
| 2012 |
Whitehurst CB, Vaziri C, Shackelford J, Pagano JS. Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites. Journal of Virology. 86: 8097-106. PMID 22623772 DOI: 10.1128/Jvi.00588-12 |
0.429 |
|
| 2011 |
Bentz GL, Whitehurst CB, Pagano JS. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. Journal of Virology. 85: 10144-53. PMID 21795333 DOI: 10.1128/Jvi.05035-11 |
0.399 |
|
| 2009 |
Wang FZ, Roy D, Gershburg E, Whitehurst CB, Dittmer DP, Pagano JS. Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication. Journal of Virology. 83: 12108-17. PMID 19759127 DOI: 10.1128/Jvi.01575-09 |
0.468 |
|
| 2009 |
Whitehurst CB, Ning S, Bentz GL, Dufour F, Gershburg E, Shackelford J, Langelier Y, Pagano JS. The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. Journal of Virology. 83: 4345-53. PMID 19244336 DOI: 10.1128/Jvi.02195-08 |
0.467 |
|
| 2007 |
Whitehurst CB, Soderblom EJ, West ML, Hernandez R, Goshe MB, Brown DT. Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins. Journal of Virology. 81: 6231-40. PMID 17409163 DOI: 10.1128/Jvi.02859-06 |
0.533 |
|
| 2006 |
Whitehurst CB, Willis JH, Sinodis CN, Hernandez R, Brown DT. Single and multiple deletions in the transmembrane domain of the Sindbis virus E2 glycoprotein identify a region critical for normal virus growth. Virology. 347: 199-207. PMID 16387341 DOI: 10.1016/J.Virol.2005.11.029 |
0.524 |
|
| Show low-probability matches. |